Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann-Alexandre Vano

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|June 30, 2024
Évolution de la prise en charge du cancer du rein : place des biomarqueurs et facteurs pronostiquesYann-Alexandre Vano
Bulletin Du Cancer|September 20, 2021
[New EMA approval: Nivolumab plus Cabozantinib for advanced renal clear cell carcinoma]Natacha Naoun, Yann-Alexandre Vano
Bulletin Du Cancer|January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical PracticeJozefina Casuscelli, Yann-Alexandre Vano, Wolf Herve Fridman, et al.
World Journal of Urology|January 2, 2021
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinomaIvan Pourmir, Johanna Noel, Audrey Simonaggio, et al.
Cancers|February 11, 2021
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest DevelopmentsAdrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, et al.
International Journal of Molecular Sciences|July 27, 2022
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsAudrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinomaMarco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Cancers|January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
Current Opinion in Immunology|March 20, 2018
Immune-based identification of cancer patients at high risk of progressionYann-Alexandre Vano, Florent Petitprez, Nicolas A Giraldo, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|June 30, 2024
Évolution de la prise en charge du cancer du rein : place des biomarqueurs et facteurs pronostiquesYann-Alexandre Vano
Bulletin Du Cancer|September 20, 2021
[New EMA approval: Nivolumab plus Cabozantinib for advanced renal clear cell carcinoma]Natacha Naoun, Yann-Alexandre Vano
Bulletin Du Cancer|January 1, 2019
Yann-Alexandre Vano, Audrey Simonaggio, Constance Thibault, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical PracticeJozefina Casuscelli, Yann-Alexandre Vano, Wolf Herve Fridman, et al.
World Journal of Urology|January 2, 2021
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinomaIvan Pourmir, Johanna Noel, Audrey Simonaggio, et al.
Cancers|February 11, 2021
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest DevelopmentsAdrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, et al.
International Journal of Molecular Sciences|July 27, 2022
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsAudrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Resistance to cancer immunotherapy in metastatic renal cell carcinomaMarco Moreira, Cedric Pobel, Nicolas Epaillard, et al.
Cancers|January 13, 2021
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, et al.
Current Opinion in Immunology|March 20, 2018
Immune-based identification of cancer patients at high risk of progressionYann-Alexandre Vano, Florent Petitprez, Nicolas A Giraldo, et al.
Pageof 5